Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
NN Farmaci AB
AB
Active
Org 5593739674
Krögers Promenad 11, 191 37
Sollentuna
Retail sale of pharmaceutical products
·
NACE 4773
Est. 2022 · 4 years old
3 employees
Monitor
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
NN Farmaci AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
35M
26M
17M
9M
0M
2022: 5M
5M
2022
2023: 22M (+340% vs 2022)
22M
+340%
2023
2024: 27M (+23% vs 2023)
27M
+23%
2024
2025: 28M (+4% vs 2024)
28M
+4%
2025
EBITDA
SEK millions
4M
3M
2M
1M
0M
2022: 2M
2M
2022
2023: 3M (+50% vs 2022)
3M
+50%
2023
2024: 1M (-67% vs 2023)
1M
-67%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
Revenue
28 110
27 389
22 333
5 234
Staff expenses
−2 733
−2 291
−2 138
−237
EBITDA
92
793
3 235
1 663
Depreciation & amort.
−252
−248
−246
−77
EBIT
−160
546
2 990
1 587
Net financials
−9
−76
−78
−47
Profit before tax
132
349
2 166
1 136
Tax
−74
−86
−454
−236
Net profit
58
263
1 712
900
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
Total assets
6 858
7 210
6 976
4 804
Equity
1 209
2 501
2 637
925
Long-term debt
800
27
295
2 164
Short-term debt
3 881
3 412
2 893
1 310
Total debt
4 681
3 440
3 189
3 475
Financial ratios
5-year trend
EBITDA margin
0,3 %
This company
15,8 %
Market median
This company
Market median
98% below market
2022
2025
Equity ratio
17,6 %
This company
38,2 %
Market median
This company
Market median
54% below market
2022
2025
Return on equity
4,8 %
This company
18,4 %
Market median
This company
Market median
74% below market
2022
2025
Net profit margin
0,2 %
This company
8,1 %
Market median
This company
Market median
98% below market
2022
2025
Asset turnover
4,10×
This company
1,12×
Market median
This company
Market median
266% above market
2022
2025
Debt / equity
4,67×
This company
0,62×
Market median
This company
Market median
653% above market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-04-04 – 2022-12-31
View
PDF
More on NN Farmaci AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
